What are the causes of direct (conjugated) hyperbilirubinemia during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Direct Hyperbilirubinemia in Pregnancy

The most common causes of direct (conjugated) hyperbilirubinemia during pregnancy are gallstones (25%), preeclampsia/eclampsia/HELLP syndrome (24%), and intrahepatic cholestasis of pregnancy (13%), with viral hepatitis no longer being a frequent etiology in the United States 1.

Pregnancy-Specific Liver Disorders

The three major pregnancy-specific conditions that cause direct hyperbilirubinemia typically present in the second and third trimesters:

Intrahepatic Cholestasis of Pregnancy (ICP)

  • Frequency: 0.3-0.5% of pregnancies 2
  • Timing: Second and third trimester
  • Key features: Pruritus is the hallmark symptom, elevated serum bile acids, bilirubin typically <5 mg/dL 2
  • Laboratory pattern: Elevated bile acids (diagnostic), mild transaminase elevation (ALT <500 U/L), alkaline phosphatase and GGT elevation 2
  • Imaging: Normal liver appearance 2
  • Critical point: Bilirubin concentrations are rarely raised in ICP, and if marked or persistent, other causes must be investigated 3

HELLP Syndrome (Hemolysis, Elevated Liver Enzymes, Low Platelets)

  • Frequency: 0.2-0.6% of pregnancies 2
  • Timing: Third trimester/postpartum
  • Key features: Abdominal pain, vomiting, proteinuria, headache, peripheral edema, always associated with preeclampsia 2
  • Laboratory pattern: Bilirubin <5 mg/dL, hemolysis, thrombocytopenia (<100 × 10⁹/L), elevated uric acid, ALT <500 U/L, elevated LDH 2
  • Imaging: May show infarcts, hematoma, or rupture; no ascites 2

Acute Fatty Liver of Pregnancy (AFLP)

  • Frequency: 0.01% of pregnancies (rare) 2
  • Timing: Third trimester/postpartum
  • Key features: Abdominal pain, vomiting, polydipsia/polyuria, hepatic encephalopathy, liver failure, DIC 2
  • Laboratory pattern: Bilirubin <5 mg/dL, hypoglycemia, elevated creatinine, elevated ammonia, ALT <500 U/L, prolonged PT, DIC in >75% 2
  • Associated findings: Preeclampsia in approximately 50% of cases 2
  • Imaging: Fatty infiltration on imaging, sometimes ascites 2

Non-Pregnancy-Specific Causes

Biliary Obstruction

  • Most common: Gallstones (25% of all cases of hyperbilirubinemia in pregnancy) 1
  • Evaluation: Liver ultrasound to assess for extrahepatic biliary obstruction 3

Viral Hepatitis

  • Current prevalence: Only 6% of cases in contemporary U.S. populations 1
  • Important shift: Despite historical teaching, viral hepatitis is no longer a common cause due to vaccination programs and demographic changes 1
  • Screening: HCV serology should be checked in differential diagnosis 3

Autoimmune Hepatitis

  • Screening tests: AMA (anti-mitochondrial antibody), ANA (antinuclear antibody), SMA (smooth muscle antibody) 3
  • Risk: Up to 30% flare rate during pregnancy in known cases 2

Chronic Liver Disease

  • Frequency: 1% of cases 1
  • Consideration: Pre-existing cirrhosis, chronic hepatitis

Other Causes

  • Sepsis 1
  • Hyperemesis gravidarum: 5% of cases 1
  • Genetic disorders: Dubin-Johnson syndrome, Gilbert syndrome with UGT1A1 polymorphisms (rare but can present with marked hyperbilirubinemia during pregnancy) 4, 5

Diagnostic Approach

When evaluating direct hyperbilirubinemia in pregnancy, the EASL guidelines 3 recommend systematically excluding:

  1. Maternal diseases with elevated bile acids: HCV serology, autoimmune hepatitis markers (AMA, ANA, SMA), liver ultrasound for biliary obstruction
  2. Pregnancy-specific disorders: Preeclampsia, AFLP, HELLP syndrome

Clinical Significance

Hyperbilirubinemia during pregnancy carries significant fetal risk 1, 6. Maternal anemia, thrombocytopenia, hyperbilirubinemia, and coagulopathy are statistically significant predictors of adverse fetal outcomes, with serum bilirubin performing better than INR as a predictor of both maternal and fetal outcomes 6.

Key Pitfall

Do not assume viral hepatitis is the cause based on outdated teaching—gallstones and preeclampsia-related disorders are now the leading etiologies in developed countries 1.

Related Questions

What are the causes of elevated bilirubin in pregnancy?
How should a one-month-old infant with a total bilirubin of 10.8 mg/dL be managed and what referral is indicated?
What is the appropriate management for a 1‑month‑old infant with a transcutaneous bilirubin level of 10.2 mg/dL?
What does a total bilirubin level of 0.03 mg/dL indicate in an otherwise healthy individual?
What does the presence of bilirubin in urine indicate and what initial evaluation is recommended?
For a patient with HIV and lymphoma on Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) and Pifeltro (ivosidenib) for 90 days, with a CD4 count of 163 cells/µL, CD4% of 16.3%, and an HIV viral load of 320 copies/mL, who recently received trimethoprim‑sulfamethoxazole (Bactrim) and acyclovir prophylaxis, should I continue or restart Pneumocystis jirovecii pneumonia prophylaxis with trimethoprim‑sulfamethoxazole, and are there any additional recommendations at this time?
What management steps should be taken for CD4 count monitoring and viral load assessment in an HIV‑positive patient with a CD4 count of 163 cells/µL?
In a 66-year-old patient with known hypothyroidism who stopped levothyroxine 25 µg for two months, how should the elevated thyroid‑stimulating hormone (TSH) and low‑normal total thyroxine (T4) be interpreted?
Which hepatitis B tests should be performed before initiating rituximab therapy?
Can a patient with chronic obstructive pulmonary disease (COPD) take doxofylline capsules daily?
What is the appropriate treatment for acute appendicitis and grade 2 fatty liver (moderate steatosis)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.